Zwitterionic Meso-Silica/polypeptide Hybrid Nanoparticles for Efficient Azithromycin Delivery and Photodynamic Therapy for Synergistic Treatment of Drug-Resistant Bacterial Infection

Ya-li Xiang,Shuang-hui Huang,Qiu-hui Hu,Qiu-yue Wang,Mei-qi Zhao,Yu-chen Jiang,Xiao Chen,Juan Lin,Qing-han Zhou
DOI: https://doi.org/10.1016/j.ijbiomac.2022.08.022
IF: 8.2
2022-01-01
International Journal of Biological Macromolecules
Abstract:The treatment of drug-resistant bacterial infections attributed to the overuse of antibiotics still remains a serious challenge globally. Herein, zwitterionic charge switchable meso-silica/polypeptide hybrid nanoparticles (MSPNs) were prepared for the synergistic chemo-photodynamic therapy in the treatment of drug-resistant bacterial infections. Subsequently, azithromycin (AZT) and methylene blue (MB) were loaded in the MSPNs to form the combined chemo-photodynamic therapeutic nanoparticles (MSPNs-AZT/MB) for the treatment of methicillin-resistant Staphylococcus aureus (MRSA). Remarkably, the as-prepared MSPNs-AZT/MB exhibited a negative surface charge of-5.2 mV at physiological pH while switching into positive surface charge of 24.7 mv in an acidic environment, leading to enhanced binding with bacterial surface. The lipase-triggered AZT release up to 77.9 % was achieved, and the loaded MB demonstrated efficient singlet oxygen (O-1(2)) generation for photodynamic therapy. The in vitro experimental results displayed an excellent antibacterial effect against MRSA in both planktonic and biofilm phenotypes. Additionally, the as-prepared MSPNs-AZT/MB exhibited synergistic and enhanced antibacterial infection effect up to 94 % comparing to monotherapy in a mice model. Considering the above advantages, the as-prepared combined chemo-photodynamic therapeutic nanoparticles showed promising biocompatibility and clinical potential for the efficient therapy of drug-resistant bacteria.
What problem does this paper attempt to address?